Pre-test probability for SARS-Cov-2-related infection score: The PARIS score
- PMID: 33332360
- PMCID: PMC7745977
- DOI: 10.1371/journal.pone.0243342
Pre-test probability for SARS-Cov-2-related infection score: The PARIS score
Abstract
Introduction: In numerous countries, large population testing is impossible due to the limited availability of RT-PCR kits and CT-scans. This study aimed to determine a pre-test probability score for SARS-CoV-2 infection.
Methods: This multicenter retrospective study (4 University Hospitals) included patients with clinical suspicion of SARS-CoV-2 infection. Demographic characteristics, clinical symptoms, and results of blood tests (complete white blood cell count, serum electrolytes and CRP) were collected. A pre-test probability score was derived from univariate analyses of clinical and biological variables between patients and controls, followed by multivariate binary logistic analysis to determine the independent variables associated with SARS-CoV-2 infection.
Results: 605 patients were included between March 10th and April 30th, 2020 (200 patients for the training cohort, 405 consecutive patients for the validation cohort). In the multivariate analysis, lymphocyte (<1.3 G/L), eosinophil (<0.06 G/L), basophil (<0.04 G/L) and neutrophil counts (<5 G/L) were associated with high probability of SARS-CoV-2 infection but no clinical variable was statistically significant. The score had a good performance in the validation cohort (AUC = 0.918 (CI: [0.891-0.946]; STD = 0.014) with a Positive Predictive Value of high-probability score of 93% (95%CI: [0.89-0.96]). Furthermore, a low-probability score excluded SARS-CoV-2 infection with a Negative Predictive Value of 98% (95%CI: [0.93-0.99]). The performance of the score was stable even during the last period of the study (15-30th April) with more controls than infected patients.
Conclusions: The PARIS score has a good performance to categorize the pre-test probability of SARS-CoV-2 infection based on complete white blood cell count. It could help clinicians adapt testing and for rapid triage of patients before test results.
Conflict of interest statement
The authors have declared that no competing interests exist.
Figures
Similar articles
-
[Repetition of microbiological tests in suspect of SARS-CoV-2 infection: utility of a score based on clinical probability].Rev Esp Quimioter. 2020 Dec;33(6):410-414. doi: 10.37201/req/080.2020. Epub 2020 Sep 11. Rev Esp Quimioter. 2020. PMID: 32935535 Free PMC article. Spanish.
-
PARIS score for evaluation of probability of SARS-CoV-2 infection in cancer patients.Support Care Cancer. 2022 Sep;30(9):7635-7643. doi: 10.1007/s00520-022-07199-9. Epub 2022 Jun 9. Support Care Cancer. 2022. PMID: 35678883 Free PMC article.
-
Impact of coronavirus disease 2019 (COVID-19) pre-test probability on positive predictive value of high cycle threshold severe acute respiratory coronavirus virus 2 (SARS-CoV-2) real-time reverse transcription polymerase chain reaction (RT-PCR) test results.Infect Control Hosp Epidemiol. 2022 Sep;43(9):1179-1183. doi: 10.1017/ice.2021.369. Epub 2021 Aug 9. Infect Control Hosp Epidemiol. 2022. PMID: 34369325 Free PMC article.
-
Effectiveness and cost-effectiveness of four different strategies for SARS-CoV-2 surveillance in the general population (CoV-Surv Study): a structured summary of a study protocol for a cluster-randomised, two-factorial controlled trial.Trials. 2021 Jan 8;22(1):39. doi: 10.1186/s13063-020-04982-z. Trials. 2021. PMID: 33419461 Free PMC article.
-
Evaluation of Diagnostic Strategies for Identifying SARS-CoV-2 Infection in Clinical Practice: a Systematic Review and Compliance with the Standards for Reporting Diagnostic Accuracy Studies Guideline (STARD).Microbiol Spectr. 2022 Aug 31;10(4):e0030022. doi: 10.1128/spectrum.00300-22. Epub 2022 Jun 14. Microbiol Spectr. 2022. PMID: 35699441 Free PMC article.
Cited by
-
Development and validation of an early warning score to identify COVID-19 in the emergency department based on routine laboratory tests: a multicentre case-control study.BMJ Open. 2022 Aug 3;12(8):e059111. doi: 10.1136/bmjopen-2021-059111. BMJ Open. 2022. PMID: 35922102 Free PMC article.
-
Eosinophils and COVID-19: diagnosis, prognosis, and vaccination strategies.Semin Immunopathol. 2021 Jun;43(3):383-392. doi: 10.1007/s00281-021-00850-3. Epub 2021 Mar 16. Semin Immunopathol. 2021. PMID: 33728484 Free PMC article. Review.
-
Assessing the capacity of symptom scores to predict COVID-19 positivity in Nigeria: a national derivation and validation cohort study.BMJ Open. 2021 Sep 3;11(9):e049699. doi: 10.1136/bmjopen-2021-049699. BMJ Open. 2021. PMID: 34479936 Free PMC article.
-
Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID-19.Cochrane Database Syst Rev. 2022 May 20;5(5):CD013665. doi: 10.1002/14651858.CD013665.pub3. Cochrane Database Syst Rev. 2022. PMID: 35593186 Free PMC article.
-
CT Examinations for COVID-19: A Systematic Review of Protocols, Radiation Dose, and Numbers Needed to Diagnose and Predict.Taehan Yongsang Uihakhoe Chi. 2021 Nov;82(6):1505-1523. doi: 10.3348/jksr.2021.0096. Epub 2021 Nov 4. Taehan Yongsang Uihakhoe Chi. 2021. PMID: 36238884 Free PMC article.
References
-
- Dong E, Du H, Gardner L. An interactive web-based dashboard to track COVID-19 in real time. Lancet Infect Dis [Internet]. 2020. February 19 [cited 2020 May 5]; Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7159018/ - PMC - PubMed
-
- Onder G, Rezza G, Brusaferro S. Case-Fatality Rate and Characteristics of Patients Dying in Relation to COVID-19 in Italy. JAMA [Internet]. 2020. March 23 [cited 2020 May 5]; Available from: https://jamanetwork.com/journals/jama/fullarticle/2763667 - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous